GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Blucora Inc. (BCOR) [hlAlert]

Rating:
Buy BCOR
down 19.59 %

Blucora Inc. (BCOR) rated Buy with price target $23 by Standpoint Research

Posted on: Monday,  Nov 3, 2014  10:25 AM ET by Standpoint Research

Standpoint Research rated Buy Blucora Inc. (NASDAQ: BCOR) on 11/03/2014, when the stock price was $16.99. Since
then, Blucora Inc. has lost 19.60% as of 01/04/2016's recent price of $13.66.
If you would have followed this Standpoint Research's recommendation on BCOR, you would have lost 19.59% of your investment in 427 days.

InfoSpace, Inc. (InfoSpace) develops search tools and technologies that assist consumers with finding content and information on the Internet. The Company offers search services that enable Internet users to locate and view content, information, merchants, individuals and products online. The Company held 40 United States registered trademarks and 75 foreign trademarks registered in various countries during the year ended December 31, 2008. InfoSpace offers search services through its Web sites, such as Dogpile.com, WebCrawler.com, MetaCrawler.com, and WebFetch.com, as well as through the Web properties of distribution partners. Partner versions of its Web offerings are private-labeled and delivered with each distribution partner?s requirements. InfoSpace uses its metasearch technology to power its branded Web sites and provide online search services to distribution partners.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/3/2014 10:25 AM Buy
None
16.99 23.00
as of 8/27/2015
1 Week down  -0.07 %
1 Month down  -16.14 %
3 Months down  -16.09 %
1 YTD down  -19.59 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy